Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver

What industry-specific factors are fueling the growth of the endocrine testing market?
The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40 rose significantly between 2022 and 2023, signaling a rapid increase in cases. Therefore, the increasing incidence of diabetes is fueling the growth of the endocrine testing market.

Get Your Endocrine Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

What Is the projected market size and growth rate for the endocrine testing market?
The endocrine testing market has grown steadily in recent years. It will expand from $2.55 billion in 2024 to $2.8 billion in 2025, at a CAGR of 9.8%. The historic growth is driven by discoveries in hormones and endocrine pathways, the standardization of diagnostic tests, public health initiatives, and the empowerment of patients.

The endocrine testing market is forecast to grow strongly, reaching $4.01 billion by 2029 at a CAGR of 9.5%. Factors driving growth include the growing prevalence of endocrine disorders, increased defense spending, aging populations, and better awareness and early diagnosis. Trends include biomarker detection advancements, omics technologies integration, AI and ML, quality assurance, and collaborative research.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What new trends are reshaping the endocrine testing market and its opportunities?
Companies in the endocrine testing market are focusing on developing point-of-care solutions to improve the accessibility and speed of diagnosing endocrine disorders. In April 2024, Roche Holding AG launched a point-of-care NT-proBNP test in India, designed to screen diabetes patients at risk of heart failure. The test enables early detection and timely interventions, improving clinical outcomes for patients at high risk of cardiovascular diseases.

What major market segments define the scope and growth of the endocrine testing market?
The endocrine testing market covered in this report is segmented -

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test
10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

Which geographical regions are pioneering growth in the endocrine testing market?
North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the endocrine testing industry growth?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

What Is Covered In The Endocrine Testing Global Market Report?

•Market Size Forecast: Examine the endocrine testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the endocrine testing market for a structured understanding.
•Key Players Overview: Analyze major players in the endocrine testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the endocrine testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the endocrine testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the endocrine testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the endocrine testing market.
•Competitive Landscape: Review strategic developments in the endocrine testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.